Exchange Traded Concepts’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,013
Closed -$1.72M 1304
2022
Q3
$1.72M Sell
7,013
-126
-2% -$34K 0.06% 168
2022
Q2
$1.77M Sell
7,139
-410
-5% -$111K 0.05% 181
2022
Q1
$2.5M Sell
7,549
-2,913
-28% -$897K 0.05% 190
2021
Q4
$3.76M Sell
10,462
-43
-0.4% -$14.5K 0.07% 161
2021
Q3
$3.42M Sell
10,505
-2,985
-22% -$1.01M 0.09% 157
2021
Q2
$4.21M Buy
13,490
+1,616
+14% +$496K 0.13% 106
2021
Q1
$3.79M Buy
11,874
+3,861
+48% +$1.24M 0.14% 104
2020
Q4
$2.6M Buy
8,013
+4,210
+111% +$1.16M 0.12% 109
2020
Q3
$1.05M Buy
3,803
+709
+23% +$204K 0.06% 157
2020
Q2
$747K Buy
3,094
+2,071
+202% +$416K 0.12% 141
2020
Q1
$148K Buy
1,023
+517
+102% +$85.8K 0.08% 222
2019
Q4
$86K Buy
+506
New +$93.8K 0.02% 218

Other funds holding ABMD

Exchange Traded Concepts's ABMD Position: Q4 2022 in Review

Exchange Traded Concepts sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 7,013 shares — an estimated $1.72M sold.

Exchange Traded Concepts first reported a position in ABMD in Q4 2019 and held it in 12 quarters. The position peaked at $4.21M in Q2 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Exchange Traded Concepts reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Exchange Traded Concepts sold 7,013 Abiomed Inc shares in Q4 2022, an estimated $1.72M.
  • Exchange Traded Concepts first reported a position in Abiomed Inc in Q4 2019 and held it in 12 quarters.
  • Exchange Traded Concepts's Abiomed Inc position peaked at $4.21M in Q2 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Exchange Traded Concepts's 13F filing for Q4 2022, filed 18 Jan 2023.